In representative samples of at least three different lungs, LTBP2 protein expression was minimal in control lungs (Fig 1E) but increased in each disease, marking parenchymal fibrosis in IPF and remodeled airways in COPD and asthma (Fig 1E-H). The gene discussed is LTBP2; the disease is chronic obstructive pulmonary disease.